A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic diseases, which is driving the need for biologics development ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 43 tables and 86 figures, this 160-page report ?Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 78 tables and 119 figures, this 215-page report ?Global Biopharmaceuticals Market 2023-2033 by Product Type, Testing ...

During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

Tempering losses, WuXi Biologics jumped 6.1 per cent to HK$19.26, while its affiliate WuXi AppTec gained 5.2 per cent HK$51.50 as they hastened stock repurchases from open market after this month's ...

Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in ...

Find insight on Tencent, TikTok, Reach and more in the latest Market Talks covering Technology, Media and Telecom.

1 Day 603259 -0.99% DJIA 0.79% S&P 500 0.91% Health Care/Life Sciences 66.70% ...

including WuXi AppTec and WuXi Biologics, as well as BGI Group, MGI and Complete Genomics. In late December, WuXi AppTec announced a deal to sell its U.S. and U.K. cell and gene unit, known as ...